Literature DB >> 11076935

Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin.

B B Bonev1, R J Gilbert, P W Andrew, O Byron, A Watts.   

Abstract

Pneumolysin, a major virulence factor of the human pathogen Streptococcus pneumoniae, is a soluble protein that disrupts cholesterol-containing membranes of cells by forming ring-shaped oligomers. Magic angle spinning and wideline static (31)P NMR have been used in combination with freeze-fracture electron microscopy to investigate the effect of pneumolysin on fully hydrated model membranes containing cholesterol and phosphatidylcholine and dicetyl phosphate (10:10:1 molar ratio). NMR spectra show that the interaction of pneumolysin with cholesterol-containing liposomes results in the formation of a nonbilayer phospholipid phase and vesicle aggregation. The amount of the nonbilayer phase increases with increasing protein concentration. Freeze-fracture electron microscopy indicates the coexistence of aggregated vesicles and free ring-shaped structures in the presence of pneumolysin. On the basis of their size and analysis of the NMR spectra it is concluded that the rings are pneumolysin oligomers (containing 30-50 monomers) complexed with lipid (each with 840-1400 lipids). The lifetime of the phospholipid in either bilayer-associated complexes or free pneumolysin-lipid complexes is > 15 ms. It is further concluded that the effect of pneumolysin on lipid membranes is a complex combination of pore formation within the bilayer, extraction of lipid into free oligomeric complexes, aggregation and fusion of liposomes, and the destabilization of membranes leading to formation of small vesicles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076935     DOI: 10.1074/jbc.M005126200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

2.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 3.  Effects of MACPF/CDC proteins on lipid membranes.

Authors:  Robert J C Gilbert; Miha Mikelj; Mauro Dalla Serra; Christopher J Froelich; Gregor Anderluh
Journal:  Cell Mol Life Sci       Date:  2012-09-15       Impact factor: 9.261

4.  The mechanism of pneumolysin-induced cochlear hair cell death in the rat.

Authors:  Maryline Beurg; Aziz Hafidi; Liam Skinner; Graeme Cowan; Yannick Hondarrague; Tim J Mitchell; Didier Dulon
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

5.  Effects of the eukaryotic pore-forming cytolysin Equinatoxin II on lipid membranes and the role of sphingomyelin.

Authors:  Boyan B Bonev; Yuen-Han Lam; Gregor Anderluh; Anthony Watts; Raymond S Norton; Frances Separovic
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

Review 6.  Cholesterol-dependent cytolysins: from water-soluble state to membrane pore.

Authors:  Michelle P Christie; Bronte A Johnstone; Rodney K Tweten; Michael W Parker; Craig J Morton
Journal:  Biophys Rev       Date:  2018-08-16

7.  The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin.

Authors:  Marcelo Nöllmann; Robert Gilbert; Timothy Mitchell; Michele Sferrazza; Olwyn Byron
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

8.  ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity.

Authors:  Marien I de Jonge; Gérard Pehau-Arnaudet; Marjan M Fretz; Felix Romain; Daria Bottai; Priscille Brodin; Nadine Honoré; Gilles Marchal; Wim Jiskoot; Patrick England; Stewart T Cole; Roland Brosch
Journal:  J Bacteriol       Date:  2007-06-08       Impact factor: 3.490

9.  Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Authors:  Mary E Marquart; Kathryn S Monds; Clare C McCormick; Sherrina N Dixon; Melissa E Sanders; Julian M Reed; Larry S McDaniel; Armando R Caballero; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

10.  Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Sidney Taylor; Nathan Tullos; Erin W Norcross; Quincy C Moore; Hilary Thompson; Lauren B King; Mary E Marquart
Journal:  BMC Ophthalmol       Date:  2013-03-11       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.